Long-Term Liabilities: The sum of all non-current liabilities.
Carisma Therapeutics Inc. (CARM) had Long-Term Liabilities of $0.61M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$45.25M |
|
$44.72M |
|
-- |
|
$45.25M |
|
$1.44M |
|
$43.81M |
|
$0.90M |
|
$44.72M |
|
$44.40M |
|
$44.72M |
|
$44.72M |
|
$44.72M |
|
$44.40M |
|
$43.81M |
|
$43.81M |
|
41.79M |
|
41.94M |
|
$1.07 |
|
$1.07 |
|
| Balance Sheet Financials | |
$5.87M |
|
-- |
|
$0.68M |
|
$6.55M |
|
$6.81M |
|
-- |
|
|
Long-Term Liabilities |
$0.61M |
$7.42M |
|
$-0.87M |
|
$-0.87M |
|
$-0.87M |
|
41.79M |
|
| Cash Flow Statement Financials | |
$-14.06M |
|
$0.69M |
|
$-1.76M |
|
$17.91M |
|
$2.78M |
|
$-15.13M |
|
$1.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
96.83% |
|
96.83% |
|
-- |
|
98.82% |
|
98.82% |
|
$-13.38M |
|
-- |
|
-- |
|
-- |
|
6.90 |
|
-- |
|
-- |
|
-- |
|
-5157.46% |
|
-5157.67% |
|
682.29% |
|
-5157.67% |
|
$-0.02 |
|
$-0.32 |
|
$-0.34 |
|